The Project: Every Child Protocol: A Registry Eligibility Screening Biology and Outcome Study
Study of Childhood Cancer Registry and Biobank
Brief description of study.
This research trial studies the Project: Every Child for younger patients with cancer. Gathering health information over time from younger patients with cancer may help doctors find better methods of treatment and on-going care.
Detailed description of study
The purpose of this study is to maintain a Childhood Cancer Registry for infants, children, adolescents, and young adults with cancer; to utilize clinical and biological data to help determine eligibility or stratification, based on childhood cancer disease classification schemas, for potential enrollment of research subjects onto Children's Oncology Group (COG) therapeutic clinical trials; to develop a well annotated childhood cancer biobank for current and future research through the collection of biospecimens (at diagnosis, time of progression, time of recurrence and/or post-mortem), including tumor, host and when feasible parental germline deoxyribonucleic acid (DNA); and key clinical data, including presentation, diagnostic, staging, summary treatment, and outcome information, from every child diagnosed with cancer at COG institutions; and to allow use of registry data for permission to be contacted in the future to consider participating in non-therapeutic and prevention research studies involving the child or their parents.
Eligibility of study
You may be eligible for this study if you meet the following criteria:
- Conditions: Childhood Lymphoma,Childhood Relapsed Solid Tumor,Central Nervous System Neoplasm,lymphoma,neoplasm,childhood,child,children,kid,kids,teen,teens,teenager,teenagers,pediatric,riley,registry,database,solid tumor,relapsed,refractory,cancer,oncology
-
Age: 25 years or below
-
Gender: All
Inclusion Criteria
In order to be eligible to take part in this trial, patients must meet the following criteria:
- Enrollment can occur at any time after disease presentation including at time of disease progression or recurrence; for patients who are to be enrolled on COG therapeutic studies, enrollment on APEC14B1 must occur prior to enrollment onto the therapeutic trial
- Subjects must be =< 25 years of age at time of original diagnosis, except for patients who are being screened specifically for eligibility onto a COG (or COG participating National Clinical Trials Network (NCTN) ) therapeutic study, for whom there is a higher upper age limit
For a full list of participation criteria, please visit clinicaltrials.gov.
This study investigates the creation and maintenance of a Childhood Cancer Registry for young patients with cancer. The purpose is to gather clinical and biological data from infants, children, adolescents, and young adults to help classify childhood cancer diseases and determine eligibility for therapeutic clinical trials. The registry will also collect biospecimens, such as tumor samples and DNA, to support current and future research.
Participants will contribute by providing health information and biospecimens at various stages, including diagnosis and recurrence. This data will be used to build a comprehensive cancer biobank and may allow participants to be contacted for future non-therapeutic and prevention studies. A biobank is a collection of biological samples and data for research purposes.
- Who can participate: Children and young adults up to 25 years old at the time of their original cancer diagnosis can participate. Enrollment is possible at any disease stage, including progression or recurrence.
- Study details: Participants will provide health information and biospecimens, such as tumor samples and DNA, at various cancer journey stages. These contributions will help build a cancer biobank for future research.
Find a site
,
Send a message
Enter your contact details to connect with study team
